ŗ£½ĒĘĘ½ā°ę

SepMateā„¢-50 (RUO)

Tube for density gradient centrifugation for research use only

Try SepMateā„¢-50 tubes for your density gradient centrifugation. Request a Sample

SepMateā„¢-50 (RUO)

Tube for density gradient centrifugation for research use only

Catalog #
(Select a product)
Tube for density gradient centrifugation for research use only
Request Pricing

Product Advantages


  • Eliminates the need for carefully layering blood over the density gradient medium (e.g. Ficoll-Paqueā„¢, ³¢²ā³¾±č³ó“Ē±č°ł±š±čā„¢ )

  • Reduces total centrifuge time to 10 minutes with the brake on for fresh samples

  • Allows fast and easy harvesting of the isolated mononuclear cells by simply pouring off the supernatant

  • Can be combined with RosetteSepā„¢ enrichment cocktails to isolate specific cell types in just 25 minutes

What's Included

  • SepMateā„¢-50 (RUO), 100 Tubes (Catalog #86450)
    • Dispenser box containing 4 bags, 25 Tubes/Bag
  • SepMateā„¢-50 (RUO), 500 Tubes (Catalog #86460)
    • Dispenser box containing 4 bags, 25 Tubes/Bag (Catalog #86450) x 5
Products for Your Protocol
To see all required products for your protocol, please consult the Protocols and Documentation.

Overview

SepMateā„¢ is a tube that facilitates the isolation of PBMCs or specific cell types by density gradient centrifugation. SepMateā„¢ tubes contain an insert that provides a barrier between the density gradient medium and blood. SepMateā„¢ eliminates the need for careful layering of blood (or bone marrow or cord blood) onto the density gradient medium, and allows for fast and easy harvesting of the isolated mononuclear cells with a simple pour. SepMateā„¢ is also compatible with RosetteSepā„¢ enrichment cocktails, allowing isolation of specific cell types in less than 30 minutes.

SepMateā„¢-50 is designed for processing samples from 4 to 17 mL of sample.

SepMateā„¢-50 (RUO) (Catalog #86450 and #86460) is manufactured under cGMP and is for Research Use Only. Users in Australia, Canada, Europe and USA, please refer to SepMateā„¢-50 (IVD) (Catalog #85450 and #85460).

Browse our Frequently Asked Questions (FAQs) on SepMateā„¢.
Contains
Polypropylene tube containing an insert
Subtype
Centrifugation Tubes
Cell Type
B Cells, Dendritic Cells, Monocytes, Mononuclear Cells, NK Cells, T Cells, T Cells, CD4+, T Cells, CD8+, T Cells, Other Subsets, T Cells, Regulatory
Species
Human
Sample Source
Bone Marrow, Cord Blood, Whole Blood
Selection Method
Negative
Application
Cell Isolation
Brand
SepMate
Area of Interest
Chimerism, HLA, Immunology

Data Figures

PBMC recovery from fresh whole blood using SepMateā„¢-50 versus standard density gradient centrifugation. Graph also shows PBMC recovery from a 48 hour-old sample using SepMateā„¢. n in each group = 7

Figure 1. Recovery of mononuclear cells (MNCs) from peripheral blood using SepMateā„¢-50 versus standard density gradient centrifiguation. Recovery of MNCs from fresh and 48-hour post blood draw enriched by density gradient centrifugation with SepMateā„¢ (purple) or without (grey). There was no significant difference in the recovery of MNCS with and without SepMateā„¢.

PBMC recovery from fresh whole blood using SepMateā„¢-50 versus standard density gradient centrifugation. Graph also shows PBMC recovery from a 48 hour-old sample using SepMateā„¢. n in each group = 7

Figure 2. Human CD4+ T Cell Isolation using SepMateā„¢-50 and RosetteSepā„¢ Human CD4+ T Cell Enrichment Cocktail

Protocols and Documentation

Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.

Document Type
Product Name
Catalog #
Lot #
Language
Document Type
Product Name
Catalog #
86450, 86460
Lot #
All
Language
English

Resources and Publications

Publications (27)

Knee loading repairs osteoporotic osteoarthritis by relieving abnormal remodeling of subchondral bone via Wnt/$\beta$-catenin signaling. W. Zheng et al. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2020 jan

Abstract

Osteoporotic osteoarthritis (OPOA) is a common bone disease mostly in the elderly, but the relationship between Osteoporotic (OP) and osteoarthritis (OA) is complex. It has been shown that knee loading can mitigate OA symptoms. However, its effects on OPOA remain unclear. In this study, we characterized pathological linkage of OP to OA, and evaluated the effect of knee loading on OPOA. We employed two mouse models (OA and OPOA), and conducted histology, cytology, and molecular analyses. In the OA and OPOA groups, articular cartilage was degenerated and Osteoarthritis Research Society International score was increased. Subchondral bone underwent abnormal remodeling, the differentiation of bone marrow mesenchymal stem cells (BMSCs) to osteoblasts and chondrocytes was reduced, and migration and adhesion of pre-osteoclasts were enhanced. Compared to the OA group, the pathological changes of OA in the OPOA group were considerably aggravated. After knee loading, however, cartilage degradation was effectively prevented, and the abnormal remodeling of subchondral bone was significantly inhibited. The differentiation of BMSCs was also improved, and the expression of Wnt/$\beta$-catenin was elevated. Collectively, this study demonstrates that osteoporosis aggravates OA symptoms. Knee loading restores OPOA by regulating subchondral bone remodeling, and may provide an effective method for repairing OPOA.
High Dimensional Mass Cytometry Analysis Reveals Characteristics of the Immunosuppressive Microenvironment in Diffuse Astrocytomas. W. Fu et al. Frontiers in oncology 2020

Abstract

The tumor immune microenvironment (TIME) plays a pivotal role in tumor development, progression, and prognosis. However, the characteristics of the TIME in diffuse astrocytoma (DA) are still unclear. Leveraging mass cytometry with a panel of 33 markers, we analyzed the infiltrating immune cells from 10 DA and 4 oligodendroglioma (OG) tissues and provided a single cell-resolution landscape of the intricate immune microenvironment. Our study profiled the composition of the TIME in DA and confirmed the presence of immune cells, such as glioma-associated microglia/macrophages (GAMs), CD8+ T cells, CD4+ T cells, regulatory T cells (Tregs), and natural killer cells. Increased percentages of PD-1+ CD8+ T cells, TIM-3+ CD4+ T cell subpopulations, Tregs and pro-tumor phenotype GAMs substantially contribute to the local immunosuppressive microenvironment in DA. DAs and OGs share similar compositions in terms of immune cells, while GAMs in DA exhibit more inhibitory characteristics than those in OG.
Identification of anti-CD16a single domain antibodies and their application in bispecific antibodies. Y. Zhao et al. Cancer biology {\&} therapy 2019 sep

Abstract

CD16a (Fc$\gamma$RIIIa) mediates the antibody dependent cellular cytotoxicity (ADCC) and is important for anti-tumor activities of many therapeutic antibodies. Bispecific antibody targeting natural killer (NK) cells has been studied for cancer therapy. In this work, anti-CD16a single-domain antibodies were identified from hCD16a immunized camel. Bispecific antibodies are then constructed by fusing these single domain antibodies with an anti-CEA single domain antibody. These bispecific antibodies can recruite NK cells to kill CEA-positive tumor cells, and inhibit tumor growth in vivo, suggesting that these anti-CD16a single domain antibodies are powerful tools to engaging NK cells for cancer therapy.
Try SepMateā„¢-50 tubes for your density gradient centrifugation. Request a Sample